StreetAlpha.app
Home › Stocks › YARW

Yarrow Bioscience, Inc. (YARW)

$12.90
▼ −9.35%
LAST CLOSE · NOV 20

Yarrow Bioscience is a New Haven biopharmaceutical company developing drugs for inflammatory and immune conditions. It last closed at $12.90 on Nov 20, down 9.35% on the day. The next earnings report for YARW is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, YARW reported EPS of -$0.43.

AI Auto Pilots
Is YARW in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold YARW.

Key Stats

Last 12 months
Results
Revenue
$482K
+1.3% vs a year ago
Net income
−$18.7M
−3881.5% margin
Operating margin
−4134.6%
−$19.9M operating income
Valuation
Market cap
$34.4M
2.7M shares
P/E
–
Price to sales
71.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.9M
At Jun 30
Debt
$0
At Jun 30
Shareholder equity
$22.1M
Shares outstanding
2.7M
At Aug 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $931K$931KFY2021FY2022: $477K$477KFY2022FY2023: $424K$424KFY2023FY2024: $501K$501KFY2024FY2025: $570K$570KFY2025

From YARW's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 13). Last 12 months adds up the four latest quarters.

Next report
Feb 11
Estimated date · Time not announced
Reported EPS
-$0.43
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Jun 2024: -$0.22Jun '24Sep 2024: -$0.29Sep '24Dec 2024: -$0.28Dec '24Mar 2025: -$0.20Mar '25Jun 2025: -$6.73Jun '25Mar 2026: -$0.08Mar '26Jun 2026: -$3.51Jun '26Sep 2026: -$0.43Sep '26Latest -$0.43
Revenue by quarter
Jun 2024: $198,000Jun '24Sep 2024: $121,000Sep '24Dec 2024: $84,000Dec '24Mar 2025: $202,000Mar '25Jun 2025: $69,000Jun '25Mar 2026: $86,000Mar '26Jun 2026: $97,000Jun '26Latest $97,000
How YARW moved after its last 2 reports
Average move the session after a report ±8.7%
Nov 12, 2026Time not announced+8.8%
Jul 28, 2026After the close+8.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on YARWStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on YARW
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on YARW

Technical Analysis

YARW · as of the Nov 20 close · updated each morning
Falling, nearing oversold

The stock is 30% below its 20 day and 58% below its 50 day average. Momentum is weak (RSI 35), near oversold. The nearest support is the 52 week low at $12.38, and the nearest resistance the Pivot at $13.38.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 17.9%/day
Key levels
$44.2852 week high+243.3%
$20.3950 day average+58.1%
$19.92Swing high (Nov 12)+54.4%
$16.8320 day average+30.5%
$14.11Pivot R1+9.4%
$13.38Pivot+3.7%
$12.90Last close
$12.3852 week low−4.0%
$12.38Swing low (Nov 5)−4.0%
$12.16Pivot S1−5.7%
Indicators
RSI (14)34.61Weak, oversold below 30Neutral
MACD-1.89Below its signal lineBearish
Stochastic17.6Near the bottom of its rangeOversold
ADX (14)37.9Trending down
Williams %R-93.2Oversold below −80, overbought above −20Oversold
CCI (20)-117.9Oversold below −100, overbought above 100Oversold
Rate of change−17.3%Change over 10 sessionsBearish
ATR (14)$2.30Typical daily range, 17.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for YARW

What happened before

See how YARW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow YARW usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How YARW has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for YARWHow many large options trades hit YARW, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

YARW Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲48 buying vs 0 selling
  • ●Shares held by funds +0.0%
  • ●Funds holding +49
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q3 2026This quarterLast quarterChange
Funds holding49––
In funds' top 101––
Held by funds–––
New / increased48 / 0––
Reduced / sold out0 / 0––
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See YARW institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

YARW Insider Trading

All filings →
Insider trading · 12 months
No open market trades in 12 months
Bought$00 buys · 0 insiders
Sold$00 sales · 0 insiders
DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Jan 15, 2025Patrick G LeporeDirectorBuy15,000$2.92$44K
Every insider buy and sale for YARW over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See YARW insider trades →

From SEC Form 4 filings by YARW's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether YARW is in one of them and how their past YARW trades turned out.

YARW in the AI portfolios
Loading…

YARW News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered YARW in an article yet. Here's the latest on the wider market.

YARW in the news

About Yarrow Bioscience

Yarrow Bioscience is a biopharmaceutical company based in New Haven, Connecticut, that develops treatments for inflammatory and immune conditions. Its work centers on BET inhibitors, a class of small molecule drugs that aim to calm overactive inflammatory signaling in the body. Its candidates are still in clinical testing and have not been approved for sale. The company's planned focus is on Graves disease and Thyroid Eye Disease, with patients and their treating doctors as the intended users of any approved treatment.

Headquarters
New Haven, CT